Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report

por Kolcava, Jan, Rajdova, Aneta, Vlckova, Eva, Stourac, Pavel, Bednarik, Josef
Publicado 2022

Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report

por Štourač, Pavel, Kolčava, Jan, Keřkovský, Miloš, Kopřivová, Tereza, Křen, Leoš, Bednařík, Josef
Publicado 2021

Obstetric anesthesia/analgesia does not affect disease course in multiple sclerosis: 10‐year retrospective cohort study

por Harazim, Hana, Štourač, Pavel, Janků, Petr, Zelinková, Hana, Frank, Kamil, Dufek, Michal, Štourač, Petr
Publicado 2018

INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

por KOCICA, Jan, KOLCAVA, Jan, SLADECKOVA, Michaela, STOURAC, Pavel, VLCKOVA, Eva, DOSBABA, Filip, KRATOCHVILOVA, Jitka, BEDNARIK, Josef
Publicado 2022

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

por PAVELEK, ZBYŠEK, VYŠATA, OLDŘICH, TAMBOR, VOJTĚCH, PIMKOVÁ, KRISTÝNA, VU, DAI LONG, KUČA, KAMIL, ŠŤOURAČ, PAVEL, VALIŠ, MARTIN
Publicado 2016

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

por Vališ, Martin, Achiron, Anat, Hartung, Hans Peter, Mareš, Jan, Tichá, Veronika, Štourač, Pavel, Halusková, Simona, Angelucci, Francesco, Pavelek, Zbyšek
Publicado 2023

Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis

por Peterka, Marek, Valis, Martin, Soucek, Ondrej, Krejsek, Jan, Sobisek, Lukáš, Sejkorova, Ilona, Klimova, Blanka, Stourac, Pavel, Pavelek, Zbysek, Novotny, Michal
Publicado 2023

Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor

por Pavelek, Zbysek, Soucek, Ondrej, Krejsek, Jan, Sejkorova, Ilona, Vysata, Oldrich, Klimová, Blanka, Angelucci, Francesco, Stourac, Pavel, Valis, Martin, Peterka, Marek, Sobisek, Lukáš, Novotny, Michal
Publicado 2023

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

por Vališ, Martin, Pavelek, Zbyšek, Novotný, Michal, Klímová, Blanka, Šarláková, Jana, Halúsková, Simona, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Vachová, Marta, Recmanová, Eva, Meluzínová, Eva
Publicado 2022

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS

por Pavelek, Zbyšek, Sobíšek, Lukáš, Šarláková, Jana, Potužník, Pavel, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Grünermelová, Markéta, Vachová, Marta, Recmanová, Eva, Angelucci, Francesco, Halúsková, Simona, Vališ, Martin
Publicado 2021

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

por Berger, Thomas, Adamczyk-Sowa, Monika, Csépány, Tünde, Fazekas, Franz, Fabjan, Tanja Hojs, Horáková, Dana, Ledinek, Alenka Horvat, Illes, Zsolt, Kobelt, Gisela, Jazbec, Saša Šega, Klímová, Eleonóra, Leutmezer, Fritz, Rejdak, Konrad, Rozsa, Csilla, Sellner, Johann, Selmaj, Krzysztof, Štouracˇ, Pavel, Szilasiová, Jarmila, Turcˇáni, Peter, Vachová, Marta, Vanecková, Manuela, Vécsei, László, Havrdová, Eva Kubala
Publicado 2020